贝伐单抗有助于消退与恶性卵巢透明细胞癌相关的心包积液和胸腔积液。
Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma.
作者信息
Ueda Tomoko, Tsubamoto Hiroshi, Eguchi Akiyo, Terada Takayuki, Shibahara Hiroaki
机构信息
Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan.
Division of Coronary Heart Disease, Department of Internal Medicine, Hyogo College of Medicine, Japan.
出版信息
Gynecol Oncol Rep. 2016 Feb 2;16:11-3. doi: 10.1016/j.gore.2016.01.006. eCollection 2016 Apr.
Abstract
•An ovarian clear cell carcinoma patient showed malignant pericardial and pleural effusion.•She subsequently experienced pulmonary embolism due to cancer progression.•Pericardial and pleural effusion were successfully treated using bevacizumab.
摘要
•一名卵巢透明细胞癌患者出现恶性心包积液和胸腔积液。
•随后，由于癌症进展，她发生了肺栓塞。
•使用贝伐单抗成功治疗了心包积液和胸腔积液。
Zotero 插件